Castle Biosciences

IPO

Innovative Molecular Prognostic and Diagnostic Tests

Public · Friendswood, United States · $51.5M raised

Headquarters
Friendswood, Texas
Employees
501–1000
Business Model
B2B
Total Funding
$51.5M
Last Round
$12.0M Series FApr 2019
Rounds
7
Type
Public

About

Castle Biosciences is a leading diagnostics company delivering advanced molecular diagnostics and prognostic tests, including genomic profiling for melanoma and other skin cancers, to guide patient care and improve outcomes.

Summary

Castle Biosciences is a Healthcare company based in Friendswood, United States. It has raised $51.5M in total across 7 rounds, most recently a $12.0M Series F round in Apr 2019. Investors include American Cancer Society BrightEdge Fund, Industry Ventures and HealthQuest Capital.

Tech & App Stack

4 technologies & apps tracked

Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.

Sign up to view funding chart

Create a free account to see funding visualizations and detailed round data.

Funding History

IPOJul 2019
$64.0M

Sign up to see all 8 rounds

Full funding history, per-round amounts, and investor participation.

Investors

Similar Companies